MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1460 blog entries.

Ovarian Suppression for PMDD: New Study Suggests Long-Term Effectiveness and Tolerability

PMDD or premenstrual dysphoric disorder has always been a bit of mystery.  We explain that PMDD is triggered by changes in reproductive hormone levels, but when you look at hormone levels in women with PMDD, [...]

By |2020-11-26T08:12:20-04:00May 17th, 2017|PMS & PMDD|Comments Off on Ovarian Suppression for PMDD: New Study Suggests Long-Term Effectiveness and Tolerability

Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression.  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially under [...]

By |2017-05-10T09:40:41-04:00May 10th, 2017|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

Weekly Roundup for MAY 5, 2017: Recent Publications in Women’s Mental Health

  A slow week.  There is more concerning data regarding the use of marijuana in pregnant women, which is prevalent in pregnant teens.  And an elegant study from Peter Schmidt and David Rubinow which gives [...]

By |2017-05-07T10:36:27-04:00May 7th, 2017|Weekly Roundup|Comments Off on Weekly Roundup for MAY 5, 2017: Recent Publications in Women’s Mental Health

Smoking During Pregnancy Not Associated with Severe Mental Illness in Offspring, But Other Risks Exist

Over the years, we have seen a number of research studies which suggested a link between maternal smoking during pregnancy and adverse psychiatric outcomes in offspring, including increased risk for bipolar disorder, schizophrenia, and attention-deficit/hyperactivity [...]

By |2020-11-26T08:29:35-04:00May 5th, 2017|Nicotine, Perinatal Substance Use|Comments Off on Smoking During Pregnancy Not Associated with Severe Mental Illness in Offspring, But Other Risks Exist

In Brief: Beta Blockers and Pregnancy, No Observed Increase in Risk of Malformations

Beta blockers are the most commonly used class of medication for treating cardiac conditions in pregnant women.  They are also effective for the treatment of anxiety symptoms, most commonly performance anxiety. According to a report [...]

By |2017-05-04T15:29:30-04:00May 4th, 2017|Anti-Anxiety Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on In Brief: Beta Blockers and Pregnancy, No Observed Increase in Risk of Malformations

More Data on Pregabalin (Lyrica) and Pregnancy

Pregabalin (marketed in the US as Lyrica) is approved by the US Food and Drug Administration for the treatment of epilepsy, fibromyalgia, and neuropathic pain.  It is also used off-label to treat psychiatric disorders, most [...]

By |2017-05-02T15:49:43-04:00May 2nd, 2017|Anti-Anxiety Medications, Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on More Data on Pregabalin (Lyrica) and Pregnancy

Weekly Roundup for APRIL 28, 2017: Recent Publications in Women’s Mental Health

The two lead articles take a look at the use of two anticonvulsants during pregnancy, lamotrigine (Lamictal) and pregabalin (Lyrica); the data are reassuring with regard to the reproductive safety of these medications. Pariente G, [...]

By |2017-05-02T09:58:47-04:00May 2nd, 2017|Weekly Roundup|Comments Off on Weekly Roundup for APRIL 28, 2017: Recent Publications in Women’s Mental Health

Neurokinin-3 Receptor Antagonists: A Novel Approach to the Treatment of Menopausal Symptoms

Over the last few years, we have seen a number of articles suggesting that the burden of menopausal symptoms is probably greater than generally perceived.  About 80% of women experience vasomotor symptoms (VMS) – hot [...]

By |2025-01-15T13:51:45-04:00April 20th, 2017|Menopausal Symptoms|Comments Off on Neurokinin-3 Receptor Antagonists: A Novel Approach to the Treatment of Menopausal Symptoms
Go to Top